Investment
Features
FeesSafety
Academy
More
Pluang+

Compare H.M. Sampoerna Tbk. (HMSP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

H.M. Sampoerna Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

H.M. Sampoerna Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp730 (market cap 86.08T, 6.17M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: H.M. Sampoerna Tbk. is far larger — about 124.5× UBC Medical Indonesia Tbk.'s market cap, and H.M. Sampoerna Tbk. is more actively traded (6.17M versus 635.5K). Which is the better fit depends on your goals.

HMSPLABS
Market Cap
86.08T691.25B
Volume
6.17M635.5K
Lot
61.7K6.36K
Turnover
4.52B110.15M
Average Price
732.19173.33
Value
4.52B110.15M
Indicative Equilibrium Price
730174
Indicative Equilibrium Volume
3.68K50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HMSP
View details
LABS
View details

About H.M. Sampoerna Tbk.

PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.

Read more on HMSP

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS